MYC and cancer: In HeLa cells, Quercetin treatment (25–50 μM) leads to the decreased expression of Chemokine (C-X-C motif) Ligand 8 (CXCL8), MYC Proto-Oncogene, BHLH Transcription Factor (MYC), IL-2, and IL-1A, molecules that play crucial roles in sustaining the inflammatory microenvironment and promoting cancer progression [101].